SEC Form 4 · accession 0001571049-16-011760

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director · 10% Owner

Period of report

Feb 10, 2016

Accepted (ET)

Feb 12, 2016 · 9:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A Common Stock^F1,F2	Feb 10, 2016	C	12,000	—	A	78,000	I	See
Class A Common Stock^F3,F4,F2	Feb 10, 2016	S	3,400	$30.78	D	74,600	I	See

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F1,F2	—	Feb 10, 2016	C	12,000	D	—	—	Class A Common Stock	12,000	20,887,811	I

F1The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
F2The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC on March 16, 2015.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.04 to $31.18, inclusive.